We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Alcohol Hand Gel Use in Mbale Regional Referral Hospital: a Cost Effectiveness Evaluation (WardGel)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02435719
Recruitment Status : Completed
First Posted : May 6, 2015
Last Update Posted : October 13, 2016
Sponsor:
Collaborators:
Mbale Regional Referral Hospital
University of Liverpool
Nagasaki University
Information provided by (Responsible Party):
Sanyu Africa Research Institute

Brief Summary:

Ministry of Health through the National Medical Stores has supplied alcohol-based handgels to the different health facilities in Uganda for the health care providers to use during clinical care. However, constant stock-outs and or limited supplies remains the main constraint faced by the hospitals. Thus the handgels are generally used by a few of the senior health care providers.

The promotion of bedside, antiseptic handrubs largely contributes to the increase in compliance and sustained improvement of hand hygiene compliance reduces Health care acquired infections (HCAIs), but it is not yet established how cost- effective the intervention is in a a rural Ugandan hospital where funds are severely rationed and, which serves over 4 million people in over 15 districts in Uganda. An evaluation of an intervention's cost-effectiveness is a crucial factor in whether the government will be prepared to fund the intervention and sustain it.

This WardGel study thus aims to assess the cost-benefit of providing hand gel for all health care workers in Mbale Regional Referral Hospital.


Condition or disease
Infections, Hospital

Show Show detailed description

Layout table for study information
Study Type : Observational
Actual Enrollment : 3626 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Effectiveness Evaluation of Alcohol Hand Gel Use in Mbale Regional Referral Hospital, Rural Eastern Uganda
Study Start Date : October 2014
Actual Primary Completion Date : May 2015
Actual Study Completion Date : May 2015

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Evidence of Hospital acquired infection confirmed clinically [ Time Frame: At least 48 hours after hospital admission or re-admission.Participants will be followed for the duration of hospital stay, an expected average of 5 days. ]
    Hospital acquired infection will be defined as new clinically diagnosed infection developed whilst an inpatient or within 2 days of discharge (for readmitted patients).


Secondary Outcome Measures :
  1. Evidence of Hospital Acquired infection confirmed by laboratory investigations (CBC and C&S) [ Time Frame: At least 48 hours after admission or readmission.Participants will be followed for the duration of hospital stay, an expected average of 5 days. ]
    Participants will be followed for the duration of hospital stay, an expected average of 5 days.

  2. Hand hygiene compliance by health care providers based on the WHO's 5-moments of Hand hygiene [ Time Frame: during patient clinical care.participants will be observed during their clinical care practice, an expected average of 30 minutes per session ]
    participants will be observed during their clinical care practice, an expected average of 30 minutes per session

  3. cost-effectiveness of hand gel use by micro-economic assessment [ Time Frame: Additional period due to confirmed hospital acquired infection.Participants will be followed for the duration of hospital stay, an expected average of 5 days. ]
    Participants will be followed for the duration of hospital stay, an expected average of 5 days.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
The study population will include in-patients and health care providers on six (6) selected wards (Labour ward, Postnatal ward, Gynaecological ward, Acute Care unit, paediatric Ward, and general surgical wards) The sample will be selected by convenience non-probability sampling method
Criteria

Inclusion Criteria:

  • Patients is admitted for at least 24 hours
  • Any health care provider, including students

Exclusion Criteria:

  • Patients discharged before 24 hours

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02435719


Locations
Layout table for location information
Uganda
Mbale Regional Referral hospital
Mbale, Uganda
Sponsors and Collaborators
Sanyu Africa Research Institute
Mbale Regional Referral Hospital
University of Liverpool
Nagasaki University
Investigators
Layout table for investigator information
Principal Investigator: Andrew Weeks, PhD University of Liverpool
Principal Investigator: James Ditai, MPH Sanyu Africa Research Institute
Principal Investigator: Benon Wanume, MMED (CP) Mbale Regional Referral Hospital
Study Director: Julian Abeso, MMED (Paed) Mbale Regional Referral Hospital
Study Director: Kyoko Inoue, MPH Nagasaki University
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Sanyu Africa Research Institute
ClinicalTrials.gov Identifier: NCT02435719    
Other Study ID Numbers: SAfRI/OBS/001
First Posted: May 6, 2015    Key Record Dates
Last Update Posted: October 13, 2016
Last Verified: October 2016
Keywords provided by Sanyu Africa Research Institute:
HCAIs
Handgel
Hospital
Effectiveness
Additional relevant MeSH terms:
Layout table for MeSH terms
Cross Infection
Infections
Iatrogenic Disease
Disease Attributes
Pathologic Processes